Showing results (2871-2880 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|August 4, 2019
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapyMichael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, et al.Cancer Immunology, Immunotherapy : CII|April 4, 2008
Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanomaWenjun Wang, Howard D Edington, Drazen M Jukic, et al.Cancer Immunology, Immunotherapy : CII|April 9, 2008
Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivoAbdeljabar El Andaloussi, Yu Han, Maciej S LesniakCancer Immunology, Immunotherapy : CII|January 1, 1991
Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducersV Feyles, W T Dixon, L K Sikora, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cellsK Y Tsang, M D Finch, F J Primus, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptorD W Beelen, H Grosse-Wilde, U Ryschka, et al.Cancer Immunology, Immunotherapy : CII|May 20, 2008
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirusLazar Vujanovic, Theresa L Whiteside, Douglas M Potter, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperationH Schild, P von Hoegen, V SchirrmacherCancer Immunology, Immunotherapy : CII|January 1, 1989
Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitroP J Guillou, P C Sedman, C W RamsdenCancer Immunology, Immunotherapy : CII|March 15, 2014
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cellsShigeo Koido, Masaki Ito, Yukiko Sagawa, et al.Pageof 652